ADARTREL

This brand name is authorized in France, Germany, Netherlands, Poland, Spain, UK.

Active ingredients

The drug ADARTREL contains one active pharmaceutical ingredient (API):

1	Ropinirole UNII D7ZD41RZI9 - ROPINIROLE HYDROCHLORIDE
	Ropinirole is a non-ergoline D2/D3 dopamine agonist which stimulates striatal dopamine receptors. Ropinirole alleviates the dopamine deficiency which characterises Parkinson’s disease by stimulating striatal dopamine receptors.
	Read more about Ropinirole

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ADARTREL Film-coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N04BC04	Ropinirole	N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BC Dopamine agonists
Discover more medicines within N04BC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00070147, 01604869, 02952785, 02952940, 04173329, 04173341, 04173358
ES	Centro de información online de medicamentos de la AEMPS	67919, 67921, 67922
FR	Base de données publique des médicaments	67276995, 69422057, 69982928
GB	Medicines & Healthcare Products Regulatory Agency	104209, 104216, 104223, 140439, 140501, 140507, 161354, 161356, 161358, 185446, 185448
NL	Z-Index G-Standaard, PRK	80519, 80527, 80535
PL	Rejestru Produktów Leczniczych	100163756, 100163762, 100163800